Business alliance with Trans Chromosomics
Dec 1,2022
iBody entered into the business alliance agreement with Trans Chromosomics which has the innovative chromosome engineering technology.
It is expected to discover more innovative antibody drug candidates by generating antibodies with Ecobody technology from fully human antibody producing mice of Trans Chromosomics.